Funding is arguably one of the most important aspects in any form of investment. In the medical world, funding means better research ability and reaching to more people. In the last 24 months, Mark Beer has been able to secure one of the most important financings for his company in the recent past.
According to the Renovia official communication, they were able to obtain a good amount of funding from two primary sources, both venture debt and a significant portion from direct investment. According to medical pundits, this funding will be instrumental in making this entity the global leader in women health.
There are many reasons why investors trusted Mark Beer in his quest for more funding. In any venture, investors want to understand the sustainability aspect of a company. It is correct to state that Renovia has one of the best business structure is the world of medical investment. Second, investors must have a clear picture of how their input will help the world.
Mark Beer is one of the best solution providers of our time, and this guarantee is one of the significant factors why investors trusted his company with $42 million worth of alternative funding. Thirdly, he has proved to be one of the most consistent people in the world of medicine because most of the Renovia flagship products are currently approved.
In addition to the above two factors, it is important to appreciate the fact that his niche of investment is not only necessary, but it is also saving lives around the world. Over the years, investment in women reproductive health has been underinvested, and according to pundits, Mark Beer investment is a game changer.
Apart from investing in one of the less invested niches, he has also taken the initiative to ensure that every step of this journey is research oriented. Research according to Mark Beer is the backbone of this company. In one of his recent interviews, he pointed out that a large amount of the funding will go to the research section of Renovia.
In addition to being keen on research, Mark Beer has also been keen on expanding the company’s human resource. He points out that having a good team is one step in achieving the company’s vision. In the last couple of years, he has brought some of the most experienced people in the world of medicine, especially in the reproductive health to his team.
Some of the most notable people he has been able to bring on board include José Bohorquez and Jessica McKinney. The two personnel are incredibly talented in research and in women health. Jessica McKinney for example is one of the most experienced people in pelvic health. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer